Soluble Epoxide Hydrolase Inhibitor Screening Kit (Fluorometric)
Lieferant: Abcam
Simplest high-throughput assay to screen thioredoxin 1 inhibitors.
- Rapid, simple and sensitive
- Convenient and HTS
- With NCND (inhibitor control)
Soluble Epoxide Hydrolase (EC 3.3.2.10) is a cytosolic enzyme with highest expression in the liver but present ubiquitously in several organs including the kidney, pancreatic islets, pituitary gland, lymphoid tissues, muscles, and the gastrointestinal tract. It catalyzes the hydrolysis of epoxyeicosatrienoic acids (EETs), i.e., epoxides derived from cytochrome P-450 mediated metabolism of arachidonic acid, to form vicinal diols.
The EETs cause vasodilation and have anti-inflammatory actions. Since the EETs are hydrolyzed to diols through soluble epoxide hydrolase, the inhibition of this enzyme is likely to enhance the beneficial properties of EETs. This makes soluble epoxide hydrolase a very useful target for cardiovascular and pain medicine.
This kit is a micro-plate based fluorometric kit for screening sEH inhibitors. Its assay principle is based on the hydrolysis of a non-fluorescent substrate to a fluorescent product by sEH. It uses N-Cyclohexyl-N'-dodecylurea (NCND), a well-known sEH inhibitor, as positive control. The kit provides a simple and fast method to screen/ characterize potential sEH inhibitors.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...